| Tag | Content |
|---|
EnhancerAtlas ID | HS020-02047 |
Organism | Homo sapiens |
Tissue/cell | CD34+ |
Coordinate | chr1:89125620-89127670 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxa2 | MA0047.2 | chr1:89126298-89126310 | GCAAAGTAAACA | - | 6.27 | | IRF1 | MA0050.2 | chr1:89126605-89126626 | TTGCAGTTTTACTTTCTCTCC | + | 6.23 | | MEF2C | MA0497.1 | chr1:89127091-89127106 | ATCTATTTTTAAAAC | - | 6.16 | | SOX10 | MA0442.2 | chr1:89127392-89127403 | AAAACAAAGGA | + | 6.32 | | Sox3 | MA0514.1 | chr1:89127392-89127402 | AAAACAAAGG | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_60200 | chr1:89125708-89152563 | Ly4 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 89126800 | 89127097 | | chr1 | 89126786 | 89126800 |
|
| | Number: 2 | ID | Chromosome | Start | End |
| GH01I088662 | chr1 | 89126684 | 89127083 | | GH01I088661 | chr1 | 89127201 | 89128760 |
|
Enhancer Sequence | TGCTTGTCTT GTTTCATCTG TACCCTCAAA CCACACACAA TCCCCTTCAC CTCCAGGCAA 60
TTTTAAAACA AACTCTAGAC ATCATTTACT GCTCAATCAT AAGTATTCTA GACTGTATCT 120
CGAAAAGAAA GGACTCTAGA AAATATTAAC CATAATATCA CTATCACACT TTTGAAATTA 180
ATACTAATTC TATAACATCA AGAAATGTGC AATTATATGC TTTCTTCTAG TGATGCAAAA 240
ACTGAAAAAA AAACCCACAA AAATCCTCCA ATAAACTGAC GAGTGAAAAA TATTATATTT 300
AAATCTTAGT TTTGATGAGT ATGTGACCAC AGCAAATTCA AATAATCCTT CTGGACCTTG 360
ATTTACCCCT CAAAAATTAA TAAATTGCCT GACCCACGTA GTTCTAATTC TCTCATAATT 420
GTTTGCAAAT AGCAGGTTAC TTAACTTTTC TAAGCTTTCA TATCTCAATA TAAAATGAGA 480
ATAATAACTA CCTTATAAAG TTGCTATGAA TATTAAAGAA GATAAAACAT GTGAAGTGCC 540
TGGCATAAAA GTAGCACTCA AAAAAAAATT AGTTATCTTT TCTTTTGAAT CCCAAACTTA 600
ACTTGAAACA ATACTGCTAC ATGTAGTTGC ATATAATCCA TGCTCTGATT TTCTCCCTCA 660
TATATTTATG AGAACCTGGC AAAGTAAACA GCTCAGTTTG TGTGTAATCC AAGGATCAGA 720
GAGATTTATT GACTTGCCCA AAGTGCACAG CTGTTGAATG GCTGAACAGA ATTTGCATAG 780
AAAGCTCCTT ACTCCCCCTG TTCTTCTGAA CCTGTGATAT CCAAAGAAAT TTAATGTGTG 840
CTTAGAATAT TCTGTTCAGA GACAGGGAGA TATATAATCA TCTTAAGAAA AAAATTCATT 900
TAGGTTATCT TTAAAATTTT TTTGAAACTT GGAGAAAGTG AAACTACCTT AAGAATTATT 960
TCTTGGGTGT TCAGTATGCC AGAAGTTGCA GTTTTACTTT CTCTCCCCAA AAAAGCCATG 1020
TAAAGGTTTT TTTAAAATTA ACCATATTGA AGCTAAAATG TCCAATTTTT TATGTAAAGT 1080
TTAACCTTTT AAAGCCAAGT GTTTATTGAC CTTCAATAAA TAATCACATT TAAAATCTGT 1140
CCATGAGAGT TTGCGATAAT TTTTAAATAC TAAACAAAAA GGGCCATATT TCTCATAAAA 1200
TGAAATTAGA AAATATTACC TAGCACTGTA GCTTGGCCAA ATGCTAACTG CAATCGGTGT 1260
TCCTATTGTA ACTTGGGTTG CAGGTGGTGT GATACTCTCC AAGCTTTCTT GATTTGGTGT 1320
ATTCAGAAAG CCAAAGTCAC GAAGTGGCTG TGGCTTCCCA GCAGCAGGTT CTCCAGTAGG 1380
AGCACACGCT CTTCAGACTC TGGCATTCAT TTCCTTAACT CACTCACTTT AAGGCCTTCT 1440
GGGTGAATGC TAGGCCTTTC TCAGCTACAA AATCTATTTT TAAAACTTTT TTTATCTCAA 1500
TGGTTTTGTA TTTTTTTTCC TTTGTATGAA TCTCACATTT CCTCTTAAGA CTGTTTCTAG 1560
GTATTTTATG TGGTTTGTTG CTACGTGGGT GAAATTCTCT TCCTTGTATT TGTTGATATA 1620
TAAGTAAATT TTCATGAGCC TAGGGTTTAA TGTTCCCTGT GAGACCTGTA TGAGAAGATA 1680
GAAGTGATGC CCCCAAACAT CTCTGGTCAT GGGTAACAAT TAACCGGAAT GGCTGGGATT 1740
CAAAATGACT TTAGACAATT AGAGAAATGT TCAAAACAAA GGATATAGTA TTGAGTGGTG 1800
GCAGGTATGA CAGAAAACAA CAACAACACA AATTATCAAA AAGAAAAGAA TAATTAGCCG 1860
ACCATGAGTG AGCATGAGGC ACTGCCCTTT TTTCTGACCG ATAAAATTGA AATCTGGTGT 1920
ATAAGGACAA TCAAACAAAC TTCCTTGTGT TTTCAGTGCC AGTGAAACCT CTAACATGAC 1980
ACCCTCTAAC TCTGACAACC ACTACTTGAA GAGAAATATA GAGATCTTAG AACCTAAGTG 2040
ATATGAACAC 2050
|
